Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness

Biochemical Pharmacology

Volumn 68, Issue 1, 2004, Pages 33-39

  Delmeire, Dominique ^a   Flamez, Daisy ^a   Moens, Karen ^a   Hinke, Simon A ^a   Van Schravendijk, Chris ^a   Pipeleers, Daniel ^a   Schuit, Frans ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

3 isobutyl 1 methylxanthine; Beta cells; Desensitization; FACS; fluorescence activated cell sorter; GIP; GIP receptor; GIP R; GLP 1; GLP 1 receptor; GLP 1 R; glucagon like peptide 1; glucose dependent insulinotropic peptide; IBMX; Insulin release

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; GLUCOSE DEPENDENT INSULINOTROPHIC PEPTIDE; INCRETIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SECRETION; CELL STIMULATION; CONTROLLED STUDY; DESENSITIZATION; DRUG EXPOSURE; DRUG MECHANISM; INSULIN RELEASE; MALE; MOLECULAR DYNAMICS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ANIMALS; DRUG COMBINATIONS; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MALE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 2942564254     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.02.035     Document Type: Article

References (30)

1. Drucker D.J. Glucagon-like peptides. Diabetes. 47:1998;159-169
2. Kieffer T.J., Habener J.F. The glucagon-like peptides. Endocr. Rev. 20:1999;876-913
3. Holst J.J., Ørskov C. Incretin hormones - an update. Scand. J. Clin. Lab. Invest. 234:2001;75-85
4. Moens K., Heimberg H., Flamez D., Huypens P., Quartier E., Ling Z., et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes. 45:1996;257-261
5. Creutzfeldt W. The incretin concept today. Diabetologia. 16:1979;75-85
6. Drucker D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 17:2003;161-171
7. Ehses J.A., Casilla V.R., Doty T., Pospisilik J.A., Demuth H.U., Pederson R.A., et al. Glucose-dependent insulinotropic polypeptide (GIP) promotes (INS-1) cell survival via cyclic AMP-mediated caspase-3 inhibition and regulation of p38 MAP kinase. Endocrinology. 144:2003;4433-4445
8. Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J. Endocrinol. 138:1993;159-166
9. Pipeleers D.G., In't Veld P.A., Van De Winkel M., Maes E., Schuit F., Gepts W. A new in vitro method for the study of pancreatic A and B cells. Endocrinology. 117:1985;806-816
10. Hoorens A., Van de Casteele M., Kloppel G., Pipeleers D. Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J. Clin. Invest. 98:1996;1568-1574
11. Pipeleers D.G., Schuit F.C., In't Veld P.A., Maes E., Hooghe-Peters E.L., Van De Winkel M., et al. Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology. 117:1985;824-833
12. Flamez D., Van Breusegem A., Scrocchi L.A., Quartier E., Pipeleers D., Drucker D.J., et al. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes. 47:1998;646-652
13. Widmann C., Dolci W., Thorens B. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Mol. Endocrinol. 10:1996;62-75
14. Fehmann H.C., Habener J.F. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells. Endocrinology. 128:1991;2880-2888
15. Thorens B., Porret A., Buhler L., Deng S.P., Morel P., Widmann C. Cloning and functional expression of the human islet GLP-1 receptor demonstration that exendin-4 is an agonist and extendin-(9-39) an antagonist of the receptor. Diabetes. 42:1993;1678-1682
16. Rakhit S., Murdoch R., Wilson S.M. Persistent desensitisation of the beta 2 adrenoceptors expressed by cultured equine sweat gland epithelial cells. J. Exp. Biol. 201:1998;259-266
17. Hui H., Yu R., Bousquet C., Perfetti R. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion. Endocrinology. 143:2002;3529-3539
18. Li Y., Hansotia T., Yusta B., Ris F., Halban P.A., Drucker D.J. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J. Biol. Chem. 278:2003;471-478
19. Hinke S.A., Pauly R.P., Ehses J., Kerridge P., Demuth H.U., McIntosh C.H., et al. Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide. J. Endocrinol. 165:2000;281-291
20. Mentlein R., Gallwitz B., Schmidt W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214:1993;829-835
21. Thum A., Hupe-Sodmann K., Goke R., Voigt K., Goke B., McGregor G.P. Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs exendins-3 and -4. Exp. Clin. Endocrinol. Diabetes. 110:2002;113-118
22. Schuit F.C., Pipeleers D.G. Regulation of adenosine 3′, 5′-monophosphate levels in the pancreatic B cell. Endocrinology. 117:1985;834-840
23. Sjöholm A., Sandberg E., Ostenson C.G., Efendic S. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells. Pancreas. 20:2000;282-289
24. Otonkoski T., Hayek A. Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1. J. Clin. Endocrinol. Metab. 80:1995;3779-3783
25. Siegel E.G., Schulze A., Schmidt W.E., Creutzfeldt W. Comparison of the effect of GIP and GLP-1 (7-36 amide) on insulin release from rat pancreatic islets. Eur. J. Clin. Invest. 22:1992;154-157
26. Suzuki S., Kawai K., Ohashi S., Watanabe Y., Yamashita K. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Metabolism. 41:1992;359-363
27. Ehses J.A., Pelech S.L., Pederson R.A., McIntosh C.H. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J. Biol. Chem. 277:2002;37088-37097
28. Mayo K.E., Miller L.J., Bataille D., Dalle S., Goke B., Thorens B., et al. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol. Rev. 55:2003;167-194
29. P Nolan AL, Lechner A, Habener JF. Microarray analysis of human islets of Langerhans treated with glucagon-like peptide-1. ADA 2003 [Abstract 1052].
30. Creutzfeldt W., Nauck M. Gut hormones and diabetes mellitus. Diabetes Metab. Rev. 8:1992;149-177